Pfizer to invest up to $500 mln in public drug developers
01 Jun Pfizer to invest up to $500 mln in public drug developers
Posted at 14:45h
in
News
by KMFSLLP
Pfizer Inc said on Tuesday it
will invest up to $500 million into publicly traded drug
developers to fund their treatment candidates and provide access
to the U.S. drugmaker’s scientific expertise.
Sorry, the comment form is closed at this time.